Carlos Gomez-Roca|Jean-Pierre Delord - JoVE Visualize

Showing results (171-180 of 223) with videos related to

Pageof 23

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid TumorsNeeltje Steeghs, Carlos Gomez-Roca, Kristoffer S Rohrberg, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2019

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 TrialR Wendel Naumann, Antoine Hollebecque, Tim Meyer, et al.

International Journal of Cancer|June 20, 2025

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancerAnouchka Modesto, Sophie Gibert, Caroline Delmas, et al.

European Journal of Cancer (Oxford, England : 1990)|July 28, 2023

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancersEdith Borcoman, Ana Lalanne, Jean-Pierre Delord, et al.

JAMA Oncology|November 2, 2018

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical TrialLillian L Siu, Caroline Even, Ricard Mesía, et al.

Targeted Oncology|October 24, 2023

A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaAlbiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, et al.

Science Translational Medicine|June 17, 2021

Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan depositionStefan Bissinger, Carina Hage, Vinona Wagner, et al.

International Journal of Cancer|September 1, 2019

From presentation to paper: Gender disparities in oncological researchWillemieke P M Dijksterhuis, Charlotte I Stroes, Wan-Ling Tan, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2016

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung CancerDavid R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.

The Lancet. Oncology|September 7, 2015

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trialChristophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, et al.

Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:

Pageof 23

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid TumorsNeeltje Steeghs, Carlos Gomez-Roca, Kristoffer S Rohrberg, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2019

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 TrialR Wendel Naumann, Antoine Hollebecque, Tim Meyer, et al.

International Journal of Cancer|June 20, 2025

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancerAnouchka Modesto, Sophie Gibert, Caroline Delmas, et al.

European Journal of Cancer (Oxford, England : 1990)|July 28, 2023

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancersEdith Borcoman, Ana Lalanne, Jean-Pierre Delord, et al.

JAMA Oncology|November 2, 2018

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical TrialLillian L Siu, Caroline Even, Ricard Mesía, et al.

Targeted Oncology|October 24, 2023

A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaAlbiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, et al.

Science Translational Medicine|June 17, 2021

Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan depositionStefan Bissinger, Carina Hage, Vinona Wagner, et al.

International Journal of Cancer|September 1, 2019

From presentation to paper: Gender disparities in oncological researchWillemieke P M Dijksterhuis, Charlotte I Stroes, Wan-Ling Tan, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2016

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung CancerDavid R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.

The Lancet. Oncology|September 7, 2015

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trialChristophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, et al.

Pageof 23